| Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
|---|
| Chain A, JmjC domain-containing histone demethylation protein 3A | 3 | 0 | 0 | 3 |
| Chain A, 2-oxoglutarate Oxygenase | 3 | 0 | 0 | 3 |
| Chain A, ATP-DEPENDENT DNA HELICASE Q1 | 2 | 0 | 0 | 2 |
| acetylcholinesterase | 3 | 0 | 0 | 3 |
| dopamine D1 receptor | 1 | 0 | 0 | 1 |
| 15-lipoxygenase, partial | 2 | 0 | 0 | 2 |
| pregnane X receptor | 2 | 0 | 0 | 2 |
| phosphopantetheinyl transferase | 5 | 0 | 0 | 5 |
| RAR-related orphan receptor gamma | 5 | 0 | 0 | 5 |
| USP1 protein, partial | 3 | 0 | 0 | 3 |
| NFKB1 protein, partial | 1 | 0 | 0 | 1 |
| Microtubule-associated protein tau | 3 | 0 | 0 | 3 |
| Thrombopoietin | 1 | 0 | 0 | 1 |
| AR protein | 7 | 0 | 0 | 7 |
| regulator of G-protein signaling 4 | 5 | 0 | 0 | 5 |
| glucocorticoid receptor [Homo sapiens] | 4 | 0 | 0 | 4 |
| retinoic acid nuclear receptor alpha variant 1 | 6 | 0 | 0 | 6 |
| retinoid X nuclear receptor alpha | 3 | 0 | 0 | 3 |
| farnesoid X nuclear receptor | 2 | 0 | 0 | 2 |
| estrogen nuclear receptor alpha | 6 | 0 | 0 | 6 |
| vitamin D (1,25- dihydroxyvitamin D3) receptor | 2 | 0 | 0 | 2 |
| arylsulfatase A | 5 | 0 | 0 | 5 |
| euchromatic histone-lysine N-methyltransferase 2 | 7 | 0 | 0 | 7 |
| Bloom syndrome protein isoform 1 | 6 | 0 | 0 | 6 |
| D(1A) dopamine receptor | 2 | 0 | 0 | 2 |
| thyroid hormone receptor beta isoform a | 2 | 0 | 0 | 2 |
| thyroid hormone receptor beta isoform 2 | 2 | 0 | 0 | 2 |
| heat shock protein beta-1 | 2 | 0 | 0 | 2 |
| flap endonuclease 1 | 3 | 0 | 0 | 3 |
| geminin | 5 | 0 | 0 | 5 |
| peripheral myelin protein 22 | 2 | 0 | 0 | 2 |
| survival motor neuron protein isoform d | 1 | 0 | 0 | 1 |
| muscarinic acetylcholine receptor M1 | 2 | 0 | 0 | 2 |
| Histone deacetylase 3 | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 6 | 0 | 1 | 0 | 1 |
| Histone deacetylase 4 | 0 | 1 | 0 | 1 |
| Guanine nucleotide-binding protein G | 1 | 0 | 0 | 1 |
| Histone deacetylase 1 | 0 | 1 | 0 | 1 |
| Histone deacetylase 7 | 0 | 1 | 0 | 1 |
| Histone deacetylase 2 | 0 | 1 | 0 | 1 |
| Polyamine deacetylase HDAC10 | 0 | 1 | 0 | 1 |
| Histone deacetylase 11 | 0 | 1 | 0 | 1 |
| Ataxin-2 | 2 | 0 | 0 | 2 |
| Histone deacetylase 8 | 0 | 1 | 0 | 1 |
| Histone deacetylase 6 | 0 | 1 | 0 | 1 |
| Histone deacetylase 9 | 0 | 1 | 0 | 1 |
| Histone deacetylase 5 | 0 | 1 | 0 | 1 |
| ATP-dependent phosphofructokinase | 5 | 0 | 0 | 5 |
| nuclear factor erythroid 2-related factor 2 isoform 1 | 4 | 0 | 0 | 4 |
| Cellular tumor antigen p53 | 5 | 0 | 0 | 5 |
| Carbonic anhydrase 1 | 0 | 0 | 0 | 3 |
| Carbonic anhydrase 2 | 0 | 1 | 0 | 4 |
| Neutral amino acid transporter A | 0 | 2 | 0 | 2 |
| Neutral amino acid transporter B(0) | 0 | 2 | 0 | 2 |
| Carbonic anhydrase-like protein, putative | 0 | 0 | 0 | 3 |
| Amino acid transporter | 0 | 2 | 0 | 2 |
| lethal factor (plasmid) | 2 | 0 | 0 | 2 |
| Cytochrome P450 3A4 | 0 | 2 | 0 | 2 |
| Sodium- and chloride-dependent GABA transporter 1 | 0 | 1 | 0 | 1 |
| Sodium- and chloride-dependent GABA transporter 2 | 0 | 2 | 0 | 2 |
| Sodium- and chloride-dependent GABA transporter 3 | 0 | 2 | 0 | 2 |
| Sodium- and chloride-dependent betaine transporter | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 1 | 0 | 3 | 1 | 5 |
| Sodium- and chloride-dependent GABA transporter 3 | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 2A | 0 | 3 | 1 | 5 |
| Glutamate receptor ionotropic, NMDA 2B | 0 | 3 | 1 | 5 |
| Glutamate receptor ionotropic, NMDA 2C | 0 | 3 | 1 | 5 |
| Glutamate receptor ionotropic, NMDA 2D | 0 | 3 | 1 | 5 |
| Proton-coupled amino acid transporter 1 | 0 | 3 | 0 | 3 |
| Glutamate receptor ionotropic, NMDA 3B | 0 | 3 | 1 | 5 |
| Sodium- and chloride-dependent GABA transporter 2 | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 3A | 0 | 3 | 1 | 5 |
| Solute carrier family 22 member 5 | 0 | 0 | 0 | 1 |
| Solute carrier family 22 member 5 | 0 | 0 | 0 | 1 |
| Bile salt export pump | 0 | 4 | 0 | 4 |
| Solute carrier family 22 member 16 | 0 | 0 | 0 | 1 |
| Solute carrier family 22 member 21 | 0 | 0 | 0 | 1 |
| Solute carrier family 22 member 5 | 0 | 0 | 0 | 1 |
| lamin isoform A-delta10 | 5 | 0 | 0 | 5 |
| Chain A, Beta-lactamase | 3 | 0 | 0 | 3 |
| glp-1 receptor, partial | 1 | 0 | 0 | 1 |
| chaperonin-containing TCP-1 beta subunit homolog | 1 | 0 | 0 | 1 |
| TDP1 protein | 2 | 0 | 0 | 2 |
| Smad3 | 1 | 0 | 0 | 1 |
| bromodomain adjacent to zinc finger domain 2B | 4 | 0 | 0 | 4 |
| IDH1 | 3 | 0 | 0 | 3 |
| ubiquitin-conjugating enzyme E2 N | 0 | 2 | 0 | 2 |
| protein AF-9 isoform a | 0 | 0 | 0 | 1 |
| histone-lysine N-methyltransferase 2A isoform 2 precursor | 3 | 0 | 0 | 3 |
| nuclear receptor ROR-gamma isoform 1 | 3 | 0 | 0 | 3 |
| 5-hydroxytryptamine receptor 4 | 0 | 4 | 0 | 4 |
| Epidermal growth factor receptor | 0 | 2 | 0 | 2 |
| Estrogen receptor | 0 | 5 | 1 | 7 |
| Receptor tyrosine-protein kinase erbB-2 | 0 | 2 | 0 | 2 |
| Tyrosine-protein kinase Fyn | 0 | 2 | 0 | 2 |
| Aldo-keto reductase family 1 member B1 | 0 | 4 | 0 | 4 |
| Muscarinic acetylcholine receptor M2 | 0 | 4 | 0 | 4 |
| Muscarinic acetylcholine receptor M4 | 0 | 4 | 0 | 4 |
| Muscarinic acetylcholine receptor M5 | 0 | 4 | 0 | 4 |
| Alpha-2A adrenergic receptor | 0 | 4 | 0 | 4 |
| Adenosine receptor A3 | 0 | 4 | 0 | 4 |
| Cytochrome P450 2D6 | 0 | 2 | 0 | 2 |
| Muscarinic acetylcholine receptor M1 | 0 | 4 | 0 | 4 |
| Beta-3 adrenergic receptor | 0 | 4 | 0 | 4 |
| Alpha-1B adrenergic receptor | 0 | 4 | 0 | 4 |
| Alpha-2B adrenergic receptor | 0 | 4 | 0 | 4 |
| Alpha-2C adrenergic receptor | 0 | 2 | 0 | 2 |
| Muscarinic acetylcholine receptor M3 | 0 | 4 | 0 | 4 |
| Substance-K receptor | 0 | 4 | 0 | 4 |
| Prostaglandin G/H synthase 1 | 0 | 2 | 0 | 2 |
| Sodium-dependent noradrenaline transporter | 0 | 4 | 0 | 4 |
| 5-hydroxytryptamine receptor 2A | 0 | 4 | 0 | 4 |
| 5-hydroxytryptamine receptor 2C | 0 | 4 | 0 | 4 |
| Sodium-dependent serotonin transporter | 0 | 4 | 0 | 4 |
| C-8 sterol isomerase | 0 | 2 | 0 | 2 |
| D(3) dopamine receptor | 0 | 4 | 0 | 4 |
| Alpha-synuclein | 2 | 0 | 0 | 2 |
| 5-hydroxytryptamine receptor 2B | 0 | 4 | 0 | 4 |
| Alpha-1A adrenergic receptor | 0 | 5 | 0 | 5 |
| 5-hydroxytryptamine receptor 6 | 0 | 4 | 0 | 4 |
| Sodium-dependent dopamine transporter | 0 | 4 | 0 | 4 |
| 3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase | 0 | 3 | 1 | 4 |
| Sigma non-opioid intracellular receptor 1 | 0 | 4 | 0 | 4 |
| Chain A, Glutamine Binding Protein | 0 | 0 | 1 | 1 |
| thioredoxin reductase | 3 | 0 | 0 | 3 |
| GLS protein | 2 | 0 | 0 | 2 |
| peripheral myelin protein 22 isoform 1 | 3 | 0 | 0 | 3 |
| Asc-type amino acid transporter 1 | 0 | 1 | 0 | 1 |
| Glycine receptor subunit alpha-1 | 0 | 0 | 1 | 1 |
| Sodium- and chloride-dependent glycine transporter 1 | 0 | 1 | 0 | 1 |
| Large neutral amino acids transporter small subunit 1 | 0 | 3 | 0 | 3 |
| Serine racemase | 0 | 1 | 0 | 1 |
| Olfactory receptor 51E2 | 0 | 0 | 1 | 1 |
| Sodium- and chloride-dependent glycine transporter 2 | 0 | 1 | 0 | 1 |
| estrogen-related nuclear receptor alpha | 4 | 0 | 0 | 4 |
| thyroid stimulating hormone receptor | 3 | 0 | 0 | 3 |
| cytochrome P450 family 3 subfamily A polypeptide 4 | 1 | 0 | 0 | 1 |
| EWS/FLI fusion protein | 3 | 0 | 0 | 3 |
| G | 1 | 0 | 0 | 1 |
| cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 3 | 0 | 0 | 3 |
| cytochrome P450 2C19 precursor | 2 | 0 | 0 | 2 |
| runt-related transcription factor 1 isoform AML1b | 1 | 0 | 0 | 1 |
| vitamin D3 receptor isoform VDRA | 2 | 0 | 0 | 2 |
| core-binding factor subunit beta isoform 2 | 1 | 0 | 0 | 1 |
| cytochrome P450 3A4 isoform 1 | 3 | 0 | 0 | 3 |
| Gamma-aminobutyric acid receptor subunit pi | 3 | 0 | 0 | 3 |
| Interferon beta | 2 | 0 | 0 | 2 |
| HLA class I histocompatibility antigen, B alpha chain | 1 | 0 | 0 | 1 |
| Steryl-sulfatase | 0 | 1 | 0 | 1 |
| Aromatase | 0 | 3 | 0 | 3 |
| Gamma-aminobutyric acid receptor subunit beta-1 | 3 | 0 | 0 | 3 |
| Cytochrome P450 11B1, mitochondrial | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit delta | 3 | 0 | 0 | 3 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | 3 | 0 | 0 | 3 |
| Cytochrome P450 11B2, mitochondrial | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | 3 | 0 | 0 | 3 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | 3 | 0 | 0 | 3 |
| Amine oxidase [flavin-containing] A | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | 3 | 0 | 0 | 3 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | 3 | 0 | 0 | 3 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | 3 | 0 | 0 | 3 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | 3 | 0 | 0 | 3 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | 3 | 0 | 0 | 3 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | 3 | 0 | 0 | 3 |
| Gamma-aminobutyric acid receptor subunit beta-3 | 3 | 0 | 0 | 3 |
| Gamma-aminobutyric acid receptor subunit beta-2 | 3 | 0 | 0 | 3 |
| GABA theta subunit | 3 | 0 | 0 | 3 |
| Inositol hexakisphosphate kinase 1 | 1 | 0 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit epsilon | 3 | 0 | 0 | 3 |
| cytochrome P450 2C9, partial | 1 | 0 | 0 | 1 |
| Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 2 | 0 | 0 | 2 |
| Chain A, HADH2 protein | 2 | 0 | 0 | 2 |
| Chain B, HADH2 protein | 2 | 0 | 0 | 2 |
| interleukin 8 | 1 | 0 | 0 | 1 |
| ClpP | 1 | 0 | 0 | 1 |
| ATAD5 protein, partial | 1 | 0 | 0 | 1 |
| GLI family zinc finger 3 | 4 | 0 | 0 | 4 |
| caspase 7, apoptosis-related cysteine protease | 2 | 0 | 0 | 2 |
| aldehyde dehydrogenase 1 family, member A1 | 2 | 0 | 0 | 2 |
| nuclear receptor subfamily 1, group I, member 3 | 3 | 0 | 0 | 3 |
| pregnane X nuclear receptor | 4 | 0 | 0 | 4 |
| caspase-3 | 2 | 0 | 0 | 2 |
| aryl hydrocarbon receptor | 3 | 0 | 0 | 3 |
| cytochrome P450 2D6 isoform 1 | 2 | 0 | 0 | 2 |
| 15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 1 | 0 | 0 | 1 |
| chromobox protein homolog 1 | 2 | 0 | 0 | 2 |
| ras-related protein Rab-9A | 2 | 0 | 0 | 2 |
| M-phase phosphoprotein 8 | 3 | 0 | 0 | 3 |
| ATP-binding cassette sub-family C member 3 | 0 | 2 | 0 | 2 |
| Multidrug resistance-associated protein 4 | 0 | 2 | 0 | 2 |
| Cytochrome P450 1A1 | 0 | 1 | 0 | 1 |
| Cytochrome P450 1A2 | 0 | 1 | 0 | 1 |
| Myeloperoxidase | 0 | 2 | 0 | 2 |
| Cytochrome P450 1A2 | 0 | 1 | 0 | 1 |
| Cholinesterase | 0 | 2 | 0 | 2 |
| Cytochrome P450 2C11 | 0 | 1 | 0 | 1 |
| Ribosyldihydronicotinamide dehydrogenase [quinone] | 0 | 2 | 0 | 2 |
| Acetylcholinesterase | 0 | 2 | 0 | 2 |
| Metabotropic glutamate receptor 1 | 0 | 1 | 0 | 1 |
| Acetylcholinesterase | 0 | 1 | 0 | 1 |
| Mu-type opioid receptor | 0 | 1 | 0 | 1 |
| Nociceptin receptor | 0 | 1 | 0 | 1 |
| Melatonin receptor type 1A | 0 | 2 | 1 | 3 |
| Melatonin receptor type 1C | 0 | 0 | 1 | 1 |
| Melatonin receptor type 1A | 0 | 1 | 1 | 2 |
| Melatonin receptor type 1B | 0 | 2 | 1 | 3 |
| Melatonin receptor type 1C | 0 | 1 | 1 | 2 |
| Melatonin receptor type 1B | 0 | 1 | 1 | 2 |
| Nuclear receptor ROR-gamma | 2 | 0 | 0 | 2 |
| Nuclear factor erythroid 2-related factor 2 | 0 | 0 | 0 | 1 |
| Cytochrome P450 1B1 | 0 | 1 | 0 | 1 |
| Palmitoleoyl-protein carboxylesterase NOTUM | 0 | 1 | 0 | 1 |
| Canalicular multispecific organic anion transporter 1 | 0 | 2 | 0 | 2 |
| Carboxylic ester hydrolase | 0 | 1 | 0 | 1 |
| Histamine H3 receptor | 0 | 1 | 0 | 1 |
| Photosystem I iron-sulfur center | 0 | 0 | 0 | 1 |
| Chain A, CES1 protein | 0 | 1 | 0 | 1 |
| Chain A, Ferritin light chain | 1 | 0 | 0 | 1 |
| hypoxia-inducible factor 1 alpha subunit | 1 | 0 | 0 | 1 |
| SMAD family member 2 | 2 | 0 | 0 | 2 |
| Fumarate hydratase | 1 | 0 | 0 | 1 |
| PPM1D protein | 1 | 0 | 0 | 1 |
| SMAD family member 3 | 2 | 0 | 0 | 2 |
| apical membrane antigen 1, AMA1 | 1 | 0 | 0 | 1 |
| DNA polymerase III, partial | 1 | 0 | 0 | 1 |
| estrogen receptor 2 (ER beta) | 1 | 0 | 0 | 1 |
| progesterone receptor | 1 | 0 | 0 | 1 |
| polyprotein | 1 | 0 | 0 | 1 |
| 67.9K protein | 1 | 0 | 0 | 1 |
| glucocerebrosidase | 2 | 0 | 0 | 2 |
| peroxisome proliferator-activated receptor delta | 3 | 0 | 0 | 3 |
| peroxisome proliferator activated receptor gamma | 3 | 0 | 0 | 3 |
| thyroid stimulating hormone receptor | 3 | 0 | 0 | 3 |
| activating transcription factor 6 | 2 | 0 | 0 | 2 |
| thyrotropin-releasing hormone receptor | 1 | 0 | 0 | 1 |
| nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 1 | 0 | 0 | 1 |
| v-jun sarcoma virus 17 oncogene homolog (avian) | 3 | 0 | 0 | 3 |
| Histone H2A.x | 2 | 0 | 0 | 2 |
| Caspase-7 | 1 | 0 | 0 | 1 |
| Spike glycoprotein | 0 | 0 | 1 | 1 |
| Replicase polyprotein 1ab | 0 | 0 | 1 | 1 |
| NPC intracellular cholesterol transporter 1 precursor | 1 | 0 | 0 | 1 |
| cellular tumor antigen p53 isoform a | 1 | 0 | 0 | 1 |
| interferon gamma precursor | 0 | 0 | 0 | 1 |
| transcriptional regulator ERG isoform 3 | 1 | 0 | 0 | 1 |
| caspase-3 | 1 | 0 | 0 | 1 |
| serine/threonine-protein kinase mTOR isoform 1 | 1 | 0 | 0 | 1 |
| streptokinase A precursor | 0 | 0 | 1 | 1 |
| Polyunsaturated fatty acid lipoxygenase ALOX15B | 1 | 0 | 0 | 1 |
| Transmembrane protease serine 2 | 0 | 0 | 1 | 1 |
| Voltage-dependent calcium channel gamma-2 subunit | 1 | 0 | 0 | 1 |
| Serine/threonine-protein kinase D3 | 0 | 1 | 0 | 1 |
| Lysosomal acid glucosylceramidase | 0 | 0 | 1 | 1 |
| Integrin beta-3 | 1 | 0 | 0 | 1 |
| Protein kinase C gamma type | 0 | 1 | 0 | 1 |
| Protein kinase C alpha type | 0 | 1 | 0 | 1 |
| Protein kinase C beta type | 0 | 1 | 0 | 1 |
| Estrogen receptor | 0 | 0 | 1 | 2 |
| Tyrosine-protein kinase Lck | 0 | 1 | 0 | 1 |
| Progesterone receptor | 0 | 1 | 0 | 1 |
| Procathepsin L | 0 | 0 | 1 | 1 |
| ATP-dependent translocase ABCB1 | 0 | 2 | 1 | 3 |
| Integrin alpha-IIb | 1 | 0 | 0 | 1 |
| Beta-1 adrenergic receptor | 0 | 2 | 0 | 2 |
| Protein kinase C delta type | 0 | 1 | 0 | 1 |
| Protein kinase C epsilon type | 0 | 1 | 0 | 1 |
| Protein kinase C zeta type | 0 | 1 | 0 | 1 |
| Polyunsaturated fatty acid 5-lipoxygenase | 0 | 1 | 0 | 1 |
| Replicase polyprotein 1a | 0 | 0 | 1 | 1 |
| Replicase polyprotein 1ab | 0 | 0 | 1 | 1 |
| Replicase polyprotein 1ab | 0 | 0 | 1 | 1 |
| Replicase polyprotein 1ab | 0 | 0 | 1 | 1 |
| Steroid hormone receptor ERR1 | 0 | 1 | 0 | 1 |
| Transcriptional activator protein LuxR | 0 | 1 | 0 | 1 |
| Angiotensin-converting enzyme | 0 | 2 | 0 | 2 |
| D(2) dopamine receptor | 0 | 2 | 0 | 2 |
| Androgen receptor | 0 | 2 | 0 | 2 |
| Protein kinase C alpha type | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 1A | 0 | 2 | 0 | 2 |
| Glutamate receptor 2 | 2 | 0 | 0 | 2 |
| Cytochrome P450 2B6 | 0 | 1 | 0 | 1 |
| D(1A) dopamine receptor | 0 | 2 | 0 | 2 |
| D(4) dopamine receptor | 0 | 2 | 0 | 2 |
| UDP-glucuronosyltransferase 1A4 | 0 | 0 | 0 | 1 |
| Thromboxane-A synthase | 0 | 1 | 0 | 1 |
| Protein kinase C eta type | 0 | 1 | 0 | 1 |
| Histamine H2 receptor | 0 | 2 | 0 | 2 |
| Alpha-1D adrenergic receptor | 0 | 2 | 0 | 2 |
| Substance-P receptor | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 1B | 0 | 2 | 0 | 2 |
| Adenosine receptor A2a | 0 | 2 | 0 | 2 |
| B2 bradykinin receptor | 0 | 2 | 0 | 2 |
| Adenosine receptor A1 | 0 | 2 | 0 | 2 |
| Melanocortin receptor 4 | 0 | 2 | 0 | 2 |
| Melanocortin receptor 5 | 0 | 2 | 0 | 2 |
| Mu-type opioid receptor | 0 | 2 | 0 | 2 |
| Delta-type opioid receptor | 0 | 2 | 0 | 2 |
| Kappa-type opioid receptor | 0 | 2 | 0 | 2 |
| Protein kinase C iota type | 0 | 1 | 0 | 1 |
| Melanocortin receptor 3 | 0 | 2 | 0 | 2 |
| Histamine H2 receptor | 1 | 0 | 0 | 1 |
| D(1A) dopamine receptor | 1 | 0 | 0 | 1 |
| Spike glycoprotein | 0 | 0 | 1 | 1 |
| Estrogen-related receptor gamma | 0 | 1 | 0 | 1 |
| Protein kinase C gamma type | 0 | 1 | 0 | 1 |
| Protein kinase C beta type | 0 | 1 | 0 | 1 |
| Phospholipase D1 | 0 | 1 | 0 | 1 |
| Protein kinase C epsilon type | 0 | 1 | 0 | 1 |
| Protein kinase C theta type | 0 | 1 | 0 | 1 |
| Protein kinase C zeta type | 0 | 1 | 0 | 1 |
| Protein kinase C delta type | 0 | 1 | 0 | 1 |
| Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform | 0 | 1 | 0 | 1 |
| Potassium voltage-gated channel subfamily H member 2 | 0 | 2 | 0 | 2 |
| Platelet-activating factor acetylhydrolase | 0 | 1 | 0 | 1 |
| Phospholipase D1 | 0 | 1 | 0 | 1 |
| Serine/threonine-protein kinase D1 | 0 | 1 | 0 | 1 |
| Estrogen receptor beta | 0 | 0 | 1 | 2 |
| Protein kinase C eta type | 0 | 1 | 0 | 1 |
| Nuclear receptor subfamily 3 group C member 3 | 0 | 2 | 0 | 2 |
| Estrogen receptor beta | 0 | 2 | 1 | 3 |
| ATPase family AAA domain-containing protein 5 | 1 | 0 | 0 | 1 |
| Emopamil-binding protein-like | 0 | 1 | 0 | 1 |
| Angiotensin-converting enzyme 2 | 0 | 0 | 1 | 1 |
| 7-dehydrocholesterol reductase | 0 | 1 | 1 | 2 |
| Protein kinase C theta type | 0 | 1 | 0 | 1 |
| Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 2 | 0 | 0 | 2 |
| Chain A, Cruzipain | 1 | 0 | 0 | 1 |
| Luciferase | 1 | 0 | 0 | 1 |
| GALC protein | 1 | 0 | 0 | 1 |
| DNA polymerase kappa isoform 1 | 2 | 0 | 0 | 2 |
| Sodium- and chloride-dependent taurine transporter | 0 | 1 | 0 | 1 |
| Ubiquitin-like modifier activating enzyme 2 | 0 | 1 | 0 | 1 |
| SUMO1 activating enzyme subunit 1 | 0 | 1 | 0 | 1 |
| heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) | 1 | 0 | 0 | 1 |
| hexokinase | 0 | 1 | 0 | 1 |
| nuclear factor erythroid 2-related factor 2 isoform 2 | 1 | 0 | 0 | 1 |
| DNA polymerase beta | 1 | 0 | 0 | 1 |
| SUMO-conjugating enzyme UBC9 | 0 | 1 | 0 | 1 |
| eukaryotic translation initiation factor 4 gamma 1 isoform 4 | 0 | 1 | 0 | 1 |
| eukaryotic translation initiation factor 4E isoform 1 | 0 | 1 | 0 | 1 |
| lethal(3)malignant brain tumor-like protein 1 isoform I | 1 | 0 | 0 | 1 |
| Vif | 0 | 1 | 0 | 1 |
| Tat | 0 | 1 | 0 | 1 |
| histone acetyltransferase KAT2A isoform 1 | 1 | 0 | 0 | 1 |
| DNA dC->dU-editing enzyme APOBEC-3G isoform 1 | 0 | 1 | 0 | 1 |
| bifunctional UDP-N-acetylglucosamine pyrophosphorylase/glucosamine-1-phosphate N-acetyltransferase | 0 | 1 | 0 | 1 |
| Aldo-keto reductase family 1 member B1 | 0 | 1 | 0 | 1 |
| Glutamate receptor 1 | 1 | 0 | 0 | 1 |
| Glutamate receptor 3 | 1 | 0 | 0 | 1 |
| Glutamate receptor 4 | 1 | 0 | 0 | 1 |
| TAR DNA-binding protein 43 | 1 | 0 | 0 | 1 |
| Chain A, Trp Rna-binding Attenuation Protein | 0 | 0 | 1 | 1 |
| Chain K, Trp Rna-binding Attenuation Protein | 0 | 0 | 1 | 1 |
| Chain B, tryptophanyl-tRNA synthetase | 0 | 0 | 1 | 1 |
| Chain C, Tryptophanyl-tRNA synthetase II | 0 | 0 | 1 | 1 |
| thioredoxin glutathione reductase | 1 | 0 | 0 | 1 |
| hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 1 | 0 | 0 | 1 |
| DNA polymerase iota isoform a (long) | 1 | 0 | 0 | 1 |
| Carbonic anhydrase 12 | 0 | 0 | 0 | 1 |
| Dihydrofolate reductase | 0 | 2 | 0 | 2 |
| Plasma kallikrein | 0 | 0 | 0 | 1 |
| Alkaline phosphatase, tissue-nonspecific isozyme | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 3 | 0 | 0 | 0 | 1 |
| Stromelysin-1 | 0 | 1 | 0 | 1 |
| Intestinal-type alkaline phosphatase | 0 | 1 | 0 | 1 |
| Indoleamine 2,3-dioxygenase 1 | 0 | 1 | 0 | 2 |
| Carbonic anhydrase 4 | 0 | 0 | 0 | 1 |
| Carbonic anhydrase 6 | 0 | 0 | 0 | 1 |
| Substance-P receptor | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 5A, mitochondrial | 0 | 0 | 0 | 1 |
| Carbonic anhydrase | 0 | 0 | 0 | 1 |
| Carbonic anhydrase 7 | 0 | 0 | 0 | 1 |
| Tryptophan 2,3-dioxygenase | 0 | 1 | 0 | 2 |
| Carbonic anhydrase | 0 | 0 | 0 | 1 |
| SLC16A10 protein | 0 | 0 | 0 | 1 |
| Uracil nucleotide/cysteinyl leukotriene receptor | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 9 | 0 | 0 | 0 | 1 |
| Carbonic anhydrase | 0 | 0 | 0 | 1 |
| Tryprostatin B synthase | 0 | 0 | 0 | 1 |
| Carbonic anhydrase | 0 | 0 | 0 | 1 |
| Carbonic anhydrase | 0 | 0 | 0 | 1 |
| 2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase | 0 | 0 | 1 | 1 |
| Carbonic anhydrase | 0 | 0 | 0 | 1 |
| Monocarboxylate transporter 10 | 0 | 0 | 0 | 1 |
| Carbonic anhydrase 15 | 0 | 0 | 0 | 1 |
| Carbonic anhydrase 13 | 0 | 0 | 0 | 1 |
| Carbonic anhydrase 14 | 0 | 0 | 0 | 1 |
| Phospholipase A-2-activating protein | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 5B, mitochondrial | 0 | 0 | 0 | 1 |
| Chain A, Arginase 1 | 0 | 1 | 0 | 1 |
| [prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |